Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use (Q90383028)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

title

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Katty Zeven

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Yannick De Vlaeminck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sandrina Martens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Cleo Goyvaerts

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Geert Raes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Marleen Keyaerts

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Karine Breckpot

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Nick Devoogdt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

5

Sam Massa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

publication date

29 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

start time

29 September 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

T cell stimulation and expansion using anti-CD3/CD28 beads

1 reference

12 December 2020

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

1 reference

12 December 2020

Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.

1 reference

12 December 2020

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems

1 reference

12 December 2020

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

1 reference

12 December 2020

Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide

1 reference

12 December 2020

Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies

1 reference

12 December 2020

LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses

1 reference

12 December 2020

Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells

1 reference

12 December 2020

Classifying Cancers Based on T-cell Infiltration and PD-L1.

1 reference

12 December 2020

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

1 reference

12 December 2020

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

1 reference

12 December 2020

Lymphocyte-activation gene-3, an important immune checkpoint in cancer

1 reference

12 December 2020

Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers

1 reference

12 December 2020

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

1 reference

12 December 2020

Expression of single-domain antibody in different systems

1 reference

12 December 2020

Immuno-PET Imaging of 89Zr Labeled Anti-PD-L1 Domain Antibody.

1 reference

12 December 2020

Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20

1 reference

12 December 2020

Anti-CTLA-4 therapy requires an Fc domain for efficacy.

1 reference

12 December 2020

Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy.

1 reference

12 December 2020

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

1 reference

12 December 2020

Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

1 reference

12 December 2020

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

1 reference

12 December 2020

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

1 reference

12 December 2020

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

1 reference

12 December 2020

Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect

1 reference

12 December 2020

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

1 reference

12 December 2020

Early Phase I Study of a 99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer

1 reference

12 December 2020

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

1 reference

12 December 2020

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

1 reference

12 December 2020

Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy

1 reference

12 December 2020

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy

1 reference

12 December 2020

LAG-3 antagonists by cancer treatment: a patent review

1 reference

12 December 2020

Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3-Knockin Mice

1 reference

12 December 2020

Targeted Nanobody-Based Molecular Tracers for Nuclear Imaging and Image-Guided Surgery

1 reference

12 December 2020

Theranostics in immuno-oncology using nanobody derivatives

1 reference

12 December 2020

Identifiers

DOI

10.3390/BIOM9100548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569553%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference